Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2893 (LINC02893)

Target
LINC02893
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2893 (LINC02893) is a human gene that encodes a long non-coding RNA (lncRNA), meaning it produces a functional RNA molecule rather than a protein product[1][3][7][9]. LINC02893 is located on chromosome 9q21.33 (9:87,008,440-87,042,419)[3]. Its official symbol is LINC02893, and it is recognized by alternative designations including AL513318.2 and BC027471[1][5][7][9]. As a lncRNA, it belongs to a class of molecules often involved in gene regulation, chromatin structure, or interacting with other RNAs and proteins, though there are no published studies confirming any specific biological role, disease association, or therapeutic relevance for LINC02893 itself[1][3][7][9]. Currently, LINC02893 is **not established as a therapeutic target** (such as a receptor, enzyme, transporter, or transcription factor), nor is it confirmed as a biomarker for disease or therapy selection, or as a target for any drugs[1][3][7][9]. The available data do not indicate any errors or misspelling regarding its identity, but rather that this gene is simply an *approved, molecularly defined lncRNA without known clinical implications or functional annotation* to date[7][9].

Other names
AL513318.2LINC02893BC027471
02

Biological functions

Other (no validated coding function; typical roles of lncRNAs include regulation of gene expression, chromatin remodeling, scaffold functions, and post-transcriptional processing, but no confirmed function is described for LINC02893 itself)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2893 (LINC02893).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2893 (LINC02893).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call